Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR3 | P29371 | 16/20 | 0.55 |
| ▸ | TACR2 | P21452 | 11/20 | 0.55 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.47 |
| ▸ | TRPV4 | Q9HBA0 | 4/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4665215 | 0.92 | TACR3 (0.57) | TACR3TACR2OPRM1KCNH2TRPV4 | |
| SCHEMBL4997500 | 0.84 | TACR3 (0.40) | TACR3TACR2OPRM1KCNH2 | |
| SCHEMBL5004652 | 0.82 | TACR3 (0.44) | TACR3TACR2OPRM1 | |
| SCHEMBL5004665 | 0.80 | TACR3 (0.40) | TACR3TACR2OPRM1KCNH2TRPV4 | |
| SCHEMBL4665961 | 0.79 | TACR3 (0.42) | TACR3TACR2OPRM1 | |
| SCHEMBL27745647 | 0.78 | TACR2 (0.73) | TACR3TACR2OPRM1TRPV4 | |
| SCHEMBL4665295 | 0.78 | TACR3 (0.41) | TACR3TACR2OPRM1KCNH2TRPV4 | |
| SCHEMBL4903021 | 0.78 | TACR3 (0.63) | TACR3TACR2OPRM1KCNH2 | |
| SCHEMBL4778600 | 0.77 | TACR3 (0.66) | TACR3TACR2OPRM1KCNH2TRPV4 | |
| Hydrochloric Acid SCHEMBL7683491 | 0.77 | TACR3 (0.62) | TACR3TACR2OPRM1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1940795-A1 | N-OXO-HETEROCYCLE AND N-OXO-ALKYL QUINOLINE-4-CARBOXAMIDES AS NK-3 RECEPTOR LIGANDS | AstraZeneca AB (SE) | 2008-07-09 | — | — | EP | disclosed |
| WO-2007035156-A1 | N-OXO-HETEROCYCLE AND N-OXO-ALKYL QUINOLINE-4-CARBOXAMIDES AS NK-3 RECEPTOR LIGANDS | ASTRAZENECA AB (SE) | 2007-03-29 | — | — | WO | disclosed |